Related Experiment Video

Updated: Apr 20, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K

Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers

Neha Singh1, Subramanian Krishnakumar2, Rupinder K Kanwar1

  • 1Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine (SoM), Faculty of Health, Deakin University, Waurn Ponds, Victoria 3217, Australia.

Drug Discovery Today
|November 30, 2014
PubMed

Insights

Drug resistance in cancer patients receiving chemotherapy is a major challenge. Targeting Survivin, an apoptosis inhibitor, shows promise in overcoming this resistance and improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Drug resistance significantly limits the efficacy of prolonged chemotherapeutic treatments in cancer patients.
  • Identifying molecules that confer drug resistance is a critical area of cancer research.
  • Survivin, an inhibitor of apoptosis protein (IAP), is a key biomarker associated with drug resistance and poor prognosis.

Purpose of the Study:

  • To highlight the role of Survivin in cancer drug resistance.
  • To discuss the potential of targeting Survivin to overcome chemotherapy resistance.
  • To emphasize Survivin as a therapeutic target for drug-resistant tumors.

Main Methods:

  • Review of current literature on drug resistance mechanisms in cancer.
  • Analysis of Survivin's function in tumor cell proliferation and survival.
  • Investigation of small molecule inhibitors targeting Survivin.

Main Results:

  • Survivin overexpression is linked to increased tumor proliferation and survival.
  • Survivin overexpression correlates positively with poor patient prognosis.
  • Targeting Survivin can potentially restore sensitivity to chemotherapeutic agents.

Conclusions:

  • Survivin is a crucial biomarker and therapeutic target for overcoming drug resistance in cancer.
  • Inhibiting Survivin offers a promising strategy for treating drug-resistant cancers.
  • Further research into Survivin-targeted therapies is warranted for improved cancer treatment.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K